BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 33416178)

  • 1. microRNA‑196a‑3p inhibits cell proliferation and promotes cell apoptosis by targeting ADP ribosylation factor 4 in diffuse large B‑cell lymphoma.
    Fu J; Lou X; Wan S; Zhao X; Chen Z; Zhu M; Guo L; Wu D; Wang S
    Oncol Rep; 2021 Feb; 45(2):764-775. PubMed ID: 33416178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-155 Downregulation Promotes Cell Cycle Arrest and Apoptosis in Diffuse Large B-Cell Lymphoma.
    Zhu FQ; Zeng L; Tang N; Tang YP; Zhou BP; Li FF; Wu WG; Zeng XB; Peng SS
    Oncol Res; 2016 Oct; 24(6):415-427. PubMed ID: 28281962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Geniposide inhibits proliferation and induces apoptosis of diffuse large B-cell lymphoma cells by inactivating the HCP5/miR-27b-3p/MET axis.
    Hu L; Zhao J; Liu Y; Liu X; Lu Q; Zeng Z; Zhu L; Tong X; Xu Q
    Int J Med Sci; 2020; 17(17):2735-2743. PubMed ID: 33162801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA SNHG16 promotes proliferation and inhibits apoptosis of diffuse large B-cell lymphoma cells by targeting miR-497-5p/PIM1 axis.
    Zhu Q; Li Y; Guo Y; Hu L; Xiao Z; Liu X; Wang J; Xu Q; Tong X
    J Cell Mol Med; 2019 Nov; 23(11):7395-7405. PubMed ID: 31483572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LINC00857 contributes to proliferation and lymphomagenesis by regulating miR-370-3p/CBX3 axis in diffuse large B-cell lymphoma.
    Huang Y; Lin Y; Song X; Wu D
    Carcinogenesis; 2021 May; 42(5):733-741. PubMed ID: 33657224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-645 regulates the proliferation and apoptosis of diffuse large B-cell lymphoma by targeting DACH1.
    Wang R; Shen J; Su N; Wang Q; Zhang M; Liu C
    Hum Cell; 2020 Oct; 33(4):1091-1098. PubMed ID: 32529465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated RNA expression of long non‑coding HOTAIR promotes cell proliferation and predicts a poor prognosis in patients with diffuse large B cell lymphoma.
    Yan Y; Han J; Li Z; Yang H; Sui Y; Wang M
    Mol Med Rep; 2016 Jun; 13(6):5125-31. PubMed ID: 27122348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-665 suppresses the progression of diffuse large B cell lymphoma (DLBCL) through targeting LIM and SH3 protein 1 (LASP1).
    Wang Y; Guo D; Li B; Wang Y; Wang B; Wang Z; Wang M; Teng Q
    Leuk Res; 2022 Jan; 112():106769. PubMed ID: 34875555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased RNA‑binding protein IGF2BP2 downregulates NT5DC2, which suppresses cell proliferation, and induces cell cycle arrest and apoptosis in diffuse large B‑cell lymphoma cells by regulating the p53 signaling pathway.
    Cui Y; Wen Y; Lv C; Zhao D; Yang Y; Qiu H; Wang C
    Mol Med Rep; 2022 Sep; 26(3):. PubMed ID: 35894142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. hsa‑miR‑429 targets CBX8 to promote cell apoptosis in diffuse large B‑cell lymphoma.
    Liang Y; Yu ZJ; Liu M; Liu HM; Zhang JZ; Xiong T; Tang YY; Huang ZP
    Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34651663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. lncRNA GAS5, as a ceRNA, inhibits the proliferation of diffuse large B‑cell lymphoma cells by regulating the miR‑18a‑5p/RUNX1 axis.
    Miao Y; Chen X; Qin M; Zhou W; Wang Y; Ji Y
    Int J Oncol; 2021 Nov; 59(5):. PubMed ID: 34698360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-26a/cyclin-dependent kinase 5 axis controls proliferation, apoptosis and in vivo tumor growth of diffuse large B-cell lymphoma cell lines.
    Farina FM; Inguscio A; Kunderfranco P; Cortesi A; Elia L; Quintavalle M
    Cell Death Dis; 2017 Jun; 8(6):e2890. PubMed ID: 28640256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CDC6, a key replication licensing factor, is overexpressed and confers poor prognosis in diffuse large B-cell lymphoma.
    Shen M; Zhang Y; Tang L; Fu Q; Zhang J; Xu Y; Zeng H; Li Y
    BMC Cancer; 2023 Oct; 23(1):978. PubMed ID: 37833632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lnc SMAD5-AS1 as ceRNA inhibit proliferation of diffuse large B cell lymphoma via Wnt/β-catenin pathway by sponging miR-135b-5p to elevate expression of APC.
    Zhao CC; Jiao Y; Zhang YY; Ning J; Zhang YR; Xu J; Wei W; Kang-Sheng G
    Cell Death Dis; 2019 Mar; 10(4):252. PubMed ID: 30874550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bortezomib inhibited the progression of diffuse large B-cell lymphoma via targeting miR-198.
    Wang R; Shen J; Wang Q; Zhang M
    Biomed Pharmacother; 2018 Dec; 108():43-49. PubMed ID: 30216798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sirt6 promotes tumorigenesis and drug resistance of diffuse large B-cell lymphoma by mediating PI3K/Akt signaling.
    Yang J; Li Y; Zhang Y; Fang X; Chen N; Zhou X; Wang X
    J Exp Clin Cancer Res; 2020 Jul; 39(1):142. PubMed ID: 32711549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-10a inhibits cell proliferation and promotes cell apoptosis by targeting BCL6 in diffuse large B-cell lymphoma.
    Fan Q; Meng X; Liang H; Zhang H; Liu X; Li L; Li W; Sun W; Zhang H; Zen K; Zhang CY; Zhou Z; Chen X; Ba Y
    Protein Cell; 2016 Dec; 7(12):899-912. PubMed ID: 27815824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential of the tumor‑derived extracellular vesicles carrying the miR‑125b‑5p target TNFAIP3 in reducing the sensitivity of diffuse large B cell lymphoma to rituximab.
    Zhang L; Zhou S; Zhou T; Li X; Tang J
    Int J Oncol; 2021 Jun; 58(6):. PubMed ID: 33887878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curcumin Inhibits the Proliferation, Migration, Invasion, and Apoptosis of Diffuse Large B-Cell Lymphoma Cell Line by Regulating MiR-21/VHL Axis.
    Chen L; Zhan CZ; Wang T; You H; Yao R
    Yonsei Med J; 2020 Jan; 61(1):20-29. PubMed ID: 31887796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of miR-126 in Diffuse Large B-Cell Lymphoma and Its Biological Function].
    Qiu C; Zhang QH; Wang GG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Oct; 30(5):1415-1422. PubMed ID: 36208243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.